Physician

Cyrus Akrami, M.D.

According to 2025 Medicare claims, Cyrus Akrami, M.D. (NPI: 1881694222) practices general practice in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is UCM MEDICAL GROUP SUB, LLC (NPI: 1467442293; TIN: 364132865) and primary practice location at 60409-5457. Akrami is affiliated with the UCMCNACO, LLC (ACO ID: A3531), participating under the MSSP model.

Akrami's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 230 traditional Medicare patients, billed 1,426 HCPCS/CPT codes, and received $83,265 in Medicare payments. The top billing code was 90662 (Influenza vaccine split virus, preservative free). Part D data shows 6,020 prescription claims across 395 beneficiaries totaling $406,618 in drug costs, led by Eliquis (Apixaban). DME data shows 72 claims. Open Payments data shows 3 records totaling $222. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $149,027 to $83,265. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $11,335 to $3,862.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	321	4,207	$149,027
2016	303	4,606	$131,865
2017	299	2,302	$133,277
2018	313	2,190	$141,269
2019	277	1,975	$127,897
2020	268	1,382	$89,512
2021	265	1,426	$122,451
2022	246	1,393	$107,460
2023	222	1,566	$71,259
2024	230	1,426	$83,265

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	260	4,596	$336,913
2016	247	4,417	$416,142
2017	269	4,389	$318,939
2018	280	4,363	$332,690
2019	277	4,418	$352,694
2020	305	4,920	$391,593
2021	357	5,559	$410,599
2022	362	5,129	$404,852
2023	357	4,981	$334,991
2024	395	6,020	$406,618

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	130	451	$13,265
2016	123	451	$8,257
2017	65	312	$5,523
2018	67	317	$4,848
2019	57	245	$4,140
2020	71	241	$5,559
2021	54	201	$7,280
2022	35	145	$8,835
2023	14	98	$4,984
2024	12	72	$1,215

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90662	Influenza vaccine split virus, preservative free	50	50	$82
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	136	206	$79
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	177	377	$64
G0008	Administration of influenza virus vaccine	62	64	$34
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	192	390	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	73	3,837	$73,330
Ozempic	Semaglutide	24	958	$27,852
Linzess	Linaclotide	32	1,560	$27,565
Farxiga	Dapagliflozin Propanediol	16	954	$18,333
Januvia	Sitagliptin Phosphate	25	930	$17,522

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	12	$639
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	12	39	$545
A4259	Lancets, per box of 100	N	N/R	21	$31

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$222	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Cyrus Akrami, M.D.?

Tedicare shows public-source Medicare data for Cyrus Akrami, M.D. (NPI 1881694222), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Cyrus Akrami, M.D. have ACO affiliation data?

Cyrus Akrami, M.D. is shown with ACO affiliation data for UCMCNACO, LLC (MSSP, ACO ID A3531).

What billing organization is linked to Cyrus Akrami, M.D.?

Cyrus Akrami, M.D. is linked to UCM MEDICAL GROUP SUB, LLC (billing NPI 1467442293) in the available physician profile data.

Does Cyrus Akrami, M.D. have Open Payments data?

Cyrus Akrami, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.